Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ian Michael Estepan Insider Profile
4 Followers
Ian Michael Estepan, CFO at Sarepta Therapeutics, holds 33.95K shares in Sarepta Therapeutics (Ticker: SRPT). Most recently, Ian Michael Estepan Sold $5,985 shares of Sarepta Therapeutics on Sep 03, 2024 for an estimated value of 822.10K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+0.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ian Michael Estepan's holdings
Insider Roles
CFO
Roles that Ian Michael Estepan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ian Michael Estepan
Ian Michael Estepan's Trading History
List of latest transactions for each holding click on a transaction to see Ian Michael Estepan's performance on stock
You May Also Like
Ian Michael Estepan insider profile FAQ
What is the percentage of profitable transactions made by Ian Michael Estepan?
The percentage of profitable transactions made by Ian Michael Estepan is 50%.
What is the average return per transaction made by Ian Michael Estepan?
The average return per transaction made by Ian Michael Estepan is 0.40%.
What stocks does Ian Michael Estepan hold?
Ian Michael Estepan holds: SRPT stocks.
What was Ian Michael Estepan’s latest transaction?
Ian Michael Estepan latest transaction was an Informative Sell of $822.10K.
What was Ian Michael Estepan's most profitable transaction?
Ian Michael Estepan’s most profitable transaction was an Informative Sell of SRPT stock on September 3, 2024. The return on the trade was 5.10%.
What is Ian Michael Estepan's role in Sarepta Therapeutics?
Ian Michael Estepan's role in Sarepta Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.